Cerity Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Cerity Partners's XENE Position: Q3 2026 in Review
Cerity Partners opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 6,484 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #2960 among its holdings.
286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Cerity Partners held 6,484 shares of Xenon Pharmaceuticals worth $241K as of Q3 2026.
- Xenon Pharmaceuticals was a new Cerity Partners position in Q3 2026.
- Xenon Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #2960 holding.
- 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.